| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |